InflaRx (IFRX) Competitors

InflaRx (NASDAQ:IFRX) and Genfit (NASDAQ:GNFT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking.

Does the MarketBeat Community favor IFRX or GNFT?

InflaRx received 177 more outperform votes than Genfit when rated by MarketBeat users. However, 69.70% of users gave Genfit an outperform vote while only 65.43% of users gave InflaRx an outperform vote.

Company	Underperform	Outperform
InflaRx	Outperform Votes 246 65.43%	Underperform Votes 130 34.57%
Genfit	Outperform Votes 69 69.70%	Underperform Votes 30 30.30%

Does the media prefer IFRX or GNFT?

In the previous week, InflaRx had 4 more articles in the media than Genfit. MarketBeat recorded 7 mentions for InflaRx and 3 mentions for Genfit. Genfit's average media sentiment score of 1.53 beat InflaRx's score of 1.00 indicating that Genfit is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InflaRx	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genfit	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility & risk, IFRX or GNFT?

InflaRx has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Genfit has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500.

Do insiders and institutionals hold more shares of IFRX or GNFT?

42.4% of InflaRx shares are held by institutional investors. Comparatively, 2.2% of Genfit shares are held by institutional investors. 16.3% of InflaRx shares are held by company insiders. Comparatively, 4.2% of Genfit shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts prefer IFRX or GNFT?

InflaRx currently has a consensus target price of $6.60, suggesting a potential upside of 725.00%. Genfit has a consensus target price of $13.00, suggesting a potential upside of 222.58%. Given InflaRx's higher probable upside, analysts clearly believe InflaRx is more favorable than Genfit.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InflaRx	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Genfit	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is IFRX or GNFT more profitable?

Genfit has a net margin of 0.00% compared to InflaRx's net margin of -33,362.70%. Genfit's return on equity of 0.00% beat InflaRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InflaRx	-33,362.70%	-65.98%	-56.86%
Genfit	N/A	N/A	N/A

Which has stronger earnings & valuation, IFRX or GNFT?

Genfit has higher revenue and earnings than InflaRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InflaRx	$129.75K	413.92	-$46.18M	-$0.82	-0.98
Genfit	$67.00M	3.01	-$31.27M	N/A	N/A

Summary

InflaRx beats Genfit on 8 of the 15 factors compared between the two stocks.